Skip to main content

Table 1 Demographics and baseline characteristics of patients with SARS-CoV-2 pneumonia

From: Clinical features and predictors for patients with severe SARS-CoV-2 pneumonia at the start of the pandemic: a retrospective multicenter cohort study

Age, years

All patients (n = 58)

Non-severe (n = 35)

Severe (n = 23)

47·8 (13·8)

46·0 (12·7)

50·5 (15·2)

Age range, years

 20–29

7 (12·1%)

5 (14·3%)

2 (8·7%)

 30–39

13 (22·4%)

8 (22·9%)

5 (21·7%)

 40–49

9 (15·5%)

6 (17·1%)

3 (13·0%)

 50–59

19 (32·8%)

11 (31·4%)

8 (34·8%)

 60–69

7 (12·1%)

5 (14·3%)

2 (8·7%)

 70–79

2 (3·5%)

0

2 (8·7%)

  ≥ 80

1 (1·7%)

0

1 (4·4%)

Gender

 Female

28 (48·3%)

22 (62·9%)

6 (26·1%)

 Male

30 (51·7%)

13 (37·1%)

17 (73·9%)

Comorbidities

 None

43 (74·1%)

28 (80·0%)

15 (65·2%)

 Hypertension

9 (15·5%)

4 (11·4%)

5 (21·7%)

 Diabetes

1 (1·7%)

0

1 (4·4%)

 Chronic kidney disease

1 (1·7%)

0

1 (4·4%)

 Malignancy

1 (1·7%)

0

1 (4·4%)

 Others

5 (8·6%)

3 (8·6%)

2 (8·7%)

Symptoms

 Fever

24 (41·4%)

12 (34·3%)

12 (52·2%)

 Cough

34 (58·6%)

22 (62·9%)

12 (52·2%)

 Sore throat

6 (10·3%)

2 (5·7%)

4 (17·4%)

 Nausea

6 (10·3%)

5 (14·3%)

1 (4·4%)

 Anorexic

5 (8·6%)

4 (11·4%)

1 (4·4%)

 Diarrhea

4 (6·9%)

3 (8·6%)

1 (4·4%)

 Muscle soreness

10 (17·2%)

6 (17·1%)

4 (17·4%)

 Dyspnea

9 (15·5%)

4 (18·2%)

5 (23·8%)

 Fatigue

18 (31·0%)

10 (28·6%)

8 (34·8%)

Severity of cough

 Absent

24 (41·4%)

13 (37·1%)

11 (47·8%)

 Mild

10 (17·2%)

9 (25·7%)

1 (4·4%)

 Moderate

18 (31·0%)

10 (28·6%)

8 (34·8%)

 Severe

6 (10·3%)

3 (8·6%)

3 (13·0%)

  1. Footnote: Data are n (%), mean (SD) or median (IQR), unless otherwise stated